Cargando…
NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
Alzheimer´s Disease (AD) is the world’s most common dementing illness. Deposition of amyloid beta peptide (Aβ) drives cerebral neuroinflammation by activating microglia(1,2). Indeed, Aβ activation of the NLRP3 inflammasome in microglia is fundamental for IL-1β maturation and subsequent inflammatory...
Autores principales: | Heneka, Michael T., Kummer, Markus P., Stutz, Andrea, Delekate, Andrea, Schwartz, Stephanie, Saecker, Ana, Griep, Angelika, Axt, Daisy, Remus, Anita, Tzeng, Te-Chen, Gelpi, Ellen, Halle, Annett, Korte, Martin, Latz, Eicke, Golenbock, Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812809/ https://www.ncbi.nlm.nih.gov/pubmed/23254930 http://dx.doi.org/10.1038/nature11729 |
Ejemplares similares
-
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
por: Kummer, Markus P, et al.
Publicado: (2021) -
Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome
por: Tejera, Dario, et al.
Publicado: (2019) -
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
por: Heneka, Michael T., et al.
Publicado: (2020) -
Pan-PPAR Modulation Effectively Protects APP/PS1 Mice from Amyloid Deposition and Cognitive Deficits
por: Kummer, Markus P., et al.
Publicado: (2014) -
NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain
por: Stutz, Andrea, et al.
Publicado: (2017)